NEW HORIZONS FOR VACCINE RESEARCH ...ec.europa.eu/research/health/pdf/participants-list-event...NEW...

5
NEW HORIZONS FOR VACCINE RESEARCH & INNOVATION CONFERENCE 12-13 March 2014 - BRUSSELS, BELGIUM DRAFT PARTICIPANTS LIST FIRST NAME LAST NAME INSTITUTION / COMPANY COUNTRY Helle Aagaard Médecins Sans Frontières Belgium Zulfikar Abbany Deutsche Welle Germany Marit Ackermann Projektträger im Deutschen Zentrum für Luft- und Raumfahrt Germany Stefan Acsinte EIB Luxemburg Karam Adel Ali EFPIA / Vaccines Europe Belgium Dissou Affolabi Faculty of health sciences, University of abomey calavi Benin Else Marie Agger Statens Serum Institut Denmark Maria Aguilar Fundación Universitaria San Pablo CEU Spain Harandi Ali University of Gothenburg Sweden Dakkak Allal Agronomic and Veterinary Hassan II Institute Morocco Neil Almond NIBSC United Kingdom Sven Amouts PROVAXS - Ghent University Belgium Clara Maria Ausiello Istituto Superiore di Sanità Italy Mathieu Azèle impulse.brussels Belgium Giorgio Barbareschi EATG-European AIDS Treatment Group Belgium Thomas Barrett European Investment Bank Luxemburg Keith Bartlett Sure Chill United Kingdom Selene Baschieri ENEA Italy •avid Bell BioKinetic Europe United Kingdom Eugenia Berioza CEERNT Belgium Florence Bietrix EATRIS Netherlands Laurent Bochereau European Commission Belgium Ahmed Bouzidi Vaxeal Switzerland Roxane Brächet Inserm-ANRS France Jeremy Bray European Commission Belgium Gianluca Breghi Sciavo Vaccines Association Italy Cushnahan Bronagh BioKinetic Europe United Kingdom Jean-Pierre Broyart CIMI-Paris Faculté de Médecine Pierre et Marie Curie France Hermann Bujard University of Heidelberg Germany Giuseppina Caligiuri INSERM U1148 France Stéphane Callewaert GSK Biologicals Belgium Corentin Chaboud Inserm France George Christophides Imperiai College London United Kingdom loanna Christopoulou VIB/University of Ghent Belgium Landry Cochard Vaccines Europe Belgium Rene Coppens TuBerculosis Vaccine Initiative (TBVI) Netherlands Andrea Corazza Global Health Advocates Belgium Mathilde Coude re Céditec - UPEC France Simon Cutting Royal Holloway University of London United Kingdom Claudia Daubenberger Swiss Tropical and Public Health Institute Switzerland Magdalena de Azero EFPIA / Vaccines Europe Belgium Michel de Baar Top Instituut Pharma Netherlands Ronald De Groot Radboud University Medical Center Netherlands Marien de Jonge Radboud university medical center Nijmegen Netherlands Giovanni De Logu Faculty of Medicine Università Cattolica del Sacro Cuore Italy David De Pooter European Scientific Working group on Influenza Belgium Joaquin de Santos Novartis Belgium Pauline de Zeeuw Cancer Institute - University College of London United Kingdom Hansi Dean International AIDS Vaccine Initiative USA Philippe Denoel GSK Vaccines Belgium Vincent Deplaigne I Care Environnement France Christian Desaintes European Commission Belgium Mahamadou Diakite Malaria Research and Training Center Mali Dimitri Diavatopoulos Radboud university medical center Netherlands Song Ding EuroVacc Foundation Netherlands Antonio Ulossa Domingos Adulai CAJ U FAC Orphanage Clinic Guinea-Bissau Ruben Dondeyne Vacci NewsNet Belgium Ruxandra Draghia-Akli European Commission Belgium Daan Du Toit South Africa Dept of S&T Belgium 1

Transcript of NEW HORIZONS FOR VACCINE RESEARCH ...ec.europa.eu/research/health/pdf/participants-list-event...NEW...

NEW HORIZONS FOR VACCINE RESEARCH & INNOVATION CONFERENCE 12-13 March 2014 - BRUSSELS, BELGIUM

DRAFT PARTICIPANTS LIST FIRST NAME LAST NAME INSTITUTION / COMPANY COUNTRY Helle Aagaard Médecins Sans Frontières Belgium Zulfikar Abbany Deutsche Welle Germany Marit Ackermann Projektträger im Deutschen Zentrum für Luft- und Raumfahrt Germany Stefan Acsinte EIB Luxemburg Karam Adel Ali EFPIA / Vaccines Europe Belgium Dissou Affolabi Faculty of health sciences, University of abomey calavi Benin Else Marie Agger Statens Serum Institut Denmark Maria Aguilar Fundación Universitaria San Pablo CEU Spain Harandi Ali University of Gothenburg Sweden Dakkak Allal Agronomic and Veterinary Hassan II Institute Morocco Neil Almond NIBSC United Kingdom Sven Amouts PROVAXS - Ghent University Belgium Clara Maria Ausiello Istituto Superiore di Sanità Italy Mathieu Azèle impulse.brussels Belgium Giorgio Barbareschi EATG-European AIDS Treatment Group Belgium Thomas Barrett European Investment Bank Luxemburg Keith Bartlett Sure Chill United Kingdom Selene Baschieri ENEA Italy •avid Bell BioKinetic Europe United Kingdom Eugenia Berioza CEERNT Belgium Florence Bietrix EATRIS Netherlands Laurent Bochereau European Commission Belgium Ahmed Bouzidi Vaxeal Switzerland Roxane Brächet Inserm-ANRS France Jeremy Bray European Commission Belgium Gianluca Breghi Sciavo Vaccines Association Italy Cushnahan Bronagh BioKinetic Europe United Kingdom Jean-Pierre Broyart CIMI-Paris Faculté de Médecine Pierre et Marie Curie France Hermann Bujard University of Heidelberg Germany Giuseppina Caligiuri INSERM U1148 France Stéphane Callewaert GSK Biologicals Belgium Corentin Chaboud Inserm France George Christophides Imperiai College London United Kingdom loanna Christopoulou VIB/University of Ghent Belgium Landry Cochard Vaccines Europe Belgium Rene Coppens TuBerculosis Vaccine Initiative (TBVI) Netherlands Andrea Corazza Global Health Advocates Belgium Mathilde Coude re Céditec - UPEC France Simon Cutting Royal Holloway University of London United Kingdom Claudia Daubenberger Swiss Tropical and Public Health Institute Switzerland Magdalena de Azero EFPIA / Vaccines Europe Belgium Michel de Baar Top Instituut Pharma Netherlands Ronald De Groot Radboud University Medical Center Netherlands Marien de Jonge Radboud university medical center Nijmegen Netherlands Giovanni De Logu Faculty of Medicine Università Cattolica del Sacro Cuore Italy David De Pooter European Scientific Working group on Influenza Belgium Joaquin de Santos Novartis Belgium Pauline de Zeeuw Cancer Institute - University College of London United Kingdom Hansi Dean International AIDS Vaccine Initiative USA Philippe Denoel GSK Vaccines Belgium Vincent Deplaigne I Care Environnement France Christian Desaintes European Commission Belgium Mahamadou Diakite Malaria Research and Training Center Mali Dimitri Diavatopoulos Radboud university medical center Netherlands Song Ding EuroVacc Foundation Netherlands Antonio Ulossa Domingos Adulai CAJ U FAC Orphanage Clinic Guinea-Bissau Ruben Dondeyne Vacci NewsNet Belgium Ruxandra Draghia-Akli European Commission Belgium Daan Du Toit South Africa Dept of S&T Belgium

1

Alison Duffin BioKinetic Europe Ltd United Kingdom Shiva Dustdar EIB Luxemburg Victoria English Evernow Publishing Ltd United Kingdom Luis Enjuanes National Center of Biotechnology (CNB-CSIC) Spain Marja Esveld Ministry of Health, Welfare and Sport Netherlands Thomas G. Evans AERAS USA Ouafaa Fassi Fihri Institut agronomique et vétérinaire Hassan II Morocco Gary Finnegan Vaccines Today Belgium Alexandra Fullem PATH Netherlands Guillaume Fusai Ministère de la recherche France Heike Galbraith Pfizer Belgium David Gancberg European Commission Belgium Felipe Garcia Hospital Clinic. Barcelona Spain Nathalie Geurts BIOMED Belgium Johan Giesecke ECDC Sweden Jill Gilmour 1 AVI / Imperial College United Kingdom Michel Goldman Innovative Medicines Initiative Belgium Marta Gomez Quintanilla CDTI Spain Nieves Gonzalez Feyecon Carbon Dioxide Technologies Netherlands Ayse Ozge Gozay TUBITAK Turkey Manfred Green Haifa University Israel Nele Hammer EUK Consulting Belgium Karin Hardt GSK Belgium Nicolas Havelange CuraVac Belgium Penny Heaton The Bill and Melinda Gates Foundation USA Cesar Henriquez HOSPITAL UNIVERSITARIO FUNDACION ALCORCON Spain Anne Herrmann DSW Belgium Adrian Hill The Jenner Institute, University of Oxford United Kingdom Ingmar Hoerr CureVac GmbH Germany Arnd Hoeveler European Commission Belgium Nigel Horscroft CureVac GmbH Germany Joppe Hovius AMC Netherlands Anne Hradský DSW Belgium Heikki Hyöty University of Tampere, School of Medicine Finland Nebojsa llic FINS Institute for Food Technology Serbia Nathalie Imbauli European Vaccine Initiative Germany David Itler Institut Pasteur France Suresh Jadhav Serum Institute of India India Anke Janssens Vaccine and Infectious Disease Institute Belgium Tuija Jansson European commission Belgium Sofie Jensen creoDK Belgium Verena Jirgal Rohde Public Policy Belgium Mark Jit Public Health England, Modelling and Economics Unit United Kingdom Stefan Jungbluth European Vaccine Initiative Germany Beate Kampmann MRC Unit, The Gambia Gambia Brigitte Keller-Stanislawski Paul-Ehrich-lnstitut Germany Charles Kelly King's College London United Kingdom Marie-Paule Kieny WHO Switzerland Maria Klimathianaki European Commission Belgium Carsten Köhler Eberhard Karls Universität Tübingen Germany Matti Kohonen Oxfam International Belgium Denis Kolbasov National institute for vet virology & microbiology Russia Kouame Kouadio Institut Pasteur of Côte d'Ivoire Côte d'Ivoire Peter Kreidl Ministry of Health Austria Austria Sine Hojdahl Kristensen Danish EU Research Office Belgium Angelika Krumina Riga Stradins University, BALTINFECT PROJECT Latvia Hannu Laang European Commission Belgium Heidi Larson London School of Hygiene and Tropical Medicine United Kingdom Leander Lauffer The PATH Malaria Vaccine Initiative USA Roger Le Grand CEA France Cynthia Lee PATH Malaria Vaccine Initiative USA Odile Leroy European Vaccine Initiative Germany Thomas Lingelbach Valneva SE Austria Vivian R. F. Linssen IMNRC-NewPOL Network Belgium Laurence Lockman GSK Vaccines Belgium

Peter Marie T. Sophie Peggy Rohit Rafael Giovanni Sascha Anandi Byron Alessandra Carlos Sonsoles Florian Line Fatme Donata Charles Tom Nathalie Kingston Rodica Fredrik Sabrina Emilio Benjamin Javier Michelle Werner Sean Musa Adriana Boubenna Adoracion Michal Andreia Louise Sandra Tom Aykut Zaneta Vered Juan Carlos Giuseppe Patricia Stephane Rune Matteo Cecile Inmaculada Ling José Anne-Françoise Lea Sejojo Irene Dirk Giulia Geert Anna Sankarasubramanian Andrea Rino Patricia Antonella

Löffler Lubs Maes Maguire Malpani Mañez Mantegazza Marschang Martin Martina Martini Martins Martin-Santamaria Matheis Matthiessen Mawas Medaglini Mgone Michiels Mielcarek Mills Mindruta-Stratan Moen Montante Mordini Mordmüller Moreno Mulder Muller Murray Musa Muscolo Nacer Navarro Torne Obuchowski Oliveira Oliver Orozco Ottenhoff Ozdarendeli Ozoliņa Padler-Karavani Palomino Pantaleo Paukovits Paul Pedersen Pedrini Peltekian Peñas Jimenez Peng Perez Petavy Pfefferle Phaaroe Plank Poelaert Povellato Preuveneers Pytko Rajaram Rappagliosi Rappuoli Reilly Riccomi

European Commission Egmont IRRI (member) WHO European Institute of Womens Health Médecins Sans Frontières Bellvitge University Hospital and Research Institute FONDAZIONE CENTRO SAN RAFFAELE European Public Health Alliance Ghent University Erasmus Medical Center European Commission Faculdade de Medicina Veterinária Universidad CEU San Pablo IDT Biologika GmbH European Commission NIBSC University of Siena / Sciavo Vaccines Association EDCTP ZN Inserm/lnstitut Pasteur de Lille Trinity College Dublin P MS I Institute of Oncology AstraZeneca Brussels Office Università Cattolica del Sacro Cuore Centre for Science, Society and Citizenship Institute of Tropical Medicine Instituto de Salud Carlos III South African Medical Research Council University of Manchester EUK Consulting The Institute of Economic Affairs Gambia università degli studi di genova INSERM DG RTD Medical University of Gdañsk DSW BioKinetic Europe Fundación Universitaria San Pablo CEU Leiden University Medical Center Erciyes University University of Latvia Tel Aviv University Ghent University Centre Hospitalier Universitaire Vaudois DG RTD Gimap UJM Saint-Etienne Rohde Public Policy MSF Supply Vaccine researc Institute VRI Inserm-ANRS European Commission CNRS CINaM UMR 7325 UCO University Lyoni Novartis Health Research and Laboratory Services European Commission GSK VACCINES GSK MS D IPPT PAN NCP-Poland AstraZeneca Vaccines Europe Novartis Vaccines and Disgnostics European Commission Istituto Superiore di Sanità

Belgium Belgium Belgium Ireland Switzerland Spain Belgium Belgium Belgium Netherlands Belgium Portugal Spain Germany Belgium United Kingdom Italy Netherlands Belgium France Ireland Republic of Moldova Belgium Belgium Italy Germany Spain South Africa United Kingdom Belgium Gambia Italy France Belgium Poland Belgium United Kingdom Spain Netherlands Turkey Latvia Israel Belgium Switzerland Belgium France Belgium Belgium France Belgium France Spain France Belgium Lesotho Belgium Belgium Belgium Belgium Poland United Kingdom Belgium Italy Belgium Italy

3

David Ritchie The Christie NHS Foundation T rust United Kingdom Sally-Anne Robinson EATRIS Netherlands Alice Rochard CVT Aviesan France Roxana Rustomjee South African Medical Research Council South Africa John F. Ryan European Commission Belgium Samia Saad Bill & Melinda Gates Foundation United Kingdom Anavaj Sakuntabhai Institut Pasteur France David Salisbury David Salisbury Consulting United Kingdom Nikolai Salnikov National research institute for veterinary virology Russia Osman Sankoh INDEPTH Network Ghana Philippe Sansonetti Institut Pasteur France Robert Sauerwein Radboud University Medical Center Netherlands Katharina Schettler DSW (Deutsche Stiftung Weltbevoelkerung) Germany Cornelius Schmaltz European Commission Belgium Corina Schmidt GSK Vaccines Belgium Rients Schootstra PurelMS B.V. Netherlands Klaus Schwamborn Valneva SE France Peter Sebo Institute of Microbiology of the ASCR, v.v.i. Czech Republic Ingar Seemann AMC Netherlands Osman Ugur Sezerman Sabanci University Turkey Anette Siedler Robert-Koch-lnsitute Germany Mathieu Simon CELLECTIS THERAPEUTICS France Babayan Simon University of Glasgow United Kingdom Inge Smolders LifeTechLimburg Belgium Hilde Somers European Commission Belgium Tim Sparwaser Twincore Germany Adrian Sprenger University of Freiburg Germany Hein Sprong National Institute of Public Health and Environment (RIVM) Netherlands Guenther Staffier AFFiRiS AG Austria Michel Stoffel GSK Vaccines Belgium Michael Sulzner European Commission DG SANCO Luxemburg Leen Suykens University of Antwerp VAXINFECTIO Belgium Anna Szczepańska EFPIA Belgium Ian Tansley Sure Chill United Kingdom Jelle Thole TuBerculosis Vaccine Initiative (TBVI) Netherlands Angus Thomson Sanofi Pasteur France Manuela Tudosia Cord Blood Europe Belgium Peter Tulkens Polit Bureau Belgium Esthel Van Brackel GSK Belgium Pierre Van Damme University of Antwerp Belgium Gianpietro van de Goor European Commission Belgium Gijsbert van de Wijdeven Bioneedle Technologies Group Netherlands Stefaan Van der Borght EC Belgium Bemard Van der Zeijst Leiden University Medical Center Netherlands Hugo Van Heuverswyn BIOMARIC Belgium Remko van Leeuwen AIGHD Netherlands Elly van Riet Intravacc Netherlands Martine van Roode Erasmus University Medical Center Rotterdam Netherlands Harry van Schooten Euvadis Netherlands Birgit Van Tongelen European Commission Belgium Stephane Vandam World Health Organization Belgium Joris Vandeputte T rivarop Belgium Vanessa Vankerckhoven Novosanis Belgium Silvia Vendetti Istituto Superiore di Sanità Italy Arno Vermeulen Immuno Valley Netherlands Fanny Voitzwinkler Global Health Advocates Belgium Gerard Voss GSK Biologicals Belgium Mathias Wambuzi UVRI-IAVI Uganda Mitchell Warren AVAC USA Sabrina Wend University of Freiburg Germany Mike Whelan iQur Limited United Kingdom Marian Wiegand AmVac Research GmbH Germany Peter Wirtz UNIVERSITY JEAN MOULIN LYON 3 France Gulderen Yanikkaya Demirel Yeditepe University School of Medicine Turkey Erik Zolcer EUK Consulting Belgium

4

Alimuddin Zumla University College London United Kingdom

5